|
ZMYM1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.101840E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.467500E-02 |
| Normal-vs-Stage2 |
7.354200E-01 |
| Normal-vs-Stage3 |
2.770000E-02 |
| Normal-vs-Stage4 |
2.807400E-01 |
| Stage1-vs-Stage2 |
4.710000E-01 |
| Stage1-vs-Stage3 |
3.988200E-01 |
| Stage1-vs-Stage4 |
9.229200E-01 |
| Stage2-vs-Stage3 |
2.432800E-01 |
| Stage2-vs-Stage4 |
7.178000E-01 |
| Stage3-vs-Stage4 |
5.141800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.258840E-01 |
| Normal-vs-AfricanAmerican |
1.197190E-01 |
| Normal-vs-Asian |
1.790190E-01 |
| Caucasian-vs-AfricanAmerican |
6.897400E-01 |
| Caucasian-vs-Asian |
7.445200E-01 |
| AfricanAmerican-vs-Asian |
8.438200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.228300E-02 |
| Normal-vs-Female |
7.711800E-01 |
| Male-vs-Female |
1.578600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.000600E-01 |
| Normal-vs-Extreme_Weight |
7.061900E-03 |
| Normal-vs-Obese |
2.953200E-01 |
| Normal-vs-Extreme_Obese |
1.781020E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.622600E-01 |
| Normal_Weight-vs-Obese |
7.589600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.193800E-01 |
| Extreme_Weight-vs-Obese |
1.719790E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.735000E-01 |
| Obese-vs-Extreme_Obese |
6.802600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.319400E-01 |
| Normal-vs-Age(41-60Yrs) |
5.078200E-01 |
| Normal-vs-Age(61-80Yrs) |
2.683500E-02 |
| Normal-vs-Age(81-100Yrs) |
5.759400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.876050E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.855700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.647670E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.069430E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.162000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.997400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.872200E-01 |
| Normal-VS-Type2 PRCC |
5.93599999999528E-05 |
| Normal-VS-KIRP CIMP |
4.115600E-01 |
| Normal-VS-Unclassified PRCC |
7.186200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.575900E-04 |
| Type1 PRCC-VS-KIRP CIMP |
2.109000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.037800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.823600E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
7.140600E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
6.411000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.737400E-03 |
| Normal-vs-N1 |
9.514000E-01 |
| Normal-vs-N2 |
2.074000E-02 |
| N0-vs-N1 |
7.871800E-02 |
| N0-vs-N2 |
4.750600E-01 |
| N1-vs-N2 |
2.227000E-01 |
|
|
